天士力集团在陕西商洛建成符合国家中药材生产质量管理规范(GAP)和欧共体GAP标准、面积达333.5hm2的种植基地,为现代中药提供了高品质药源保障。 我国中药药源生产一直处于没有标准的混乱状态,因而导致“农残”超标和重金属超标,有效成分含量低而且质量不稳定,这不仅严重制约 Tasly Group established a planting base of 333.5hm2 in conformity with the GAP (Quality Management Practices of Chinese Medicinal Herbs) and GAP standard of the European Community in Shangluo, Shaanxi Province, which provided high-quality source protection for modern Chinese medicine. China’s traditional Chinese medicine source production has been in a state of no standard chaos, resulting in “pesticide residues” excessive and excessive heavy metals, the active ingredient content is low and the quality is not stable, not only severely restricted